COMPARISON OF DEMOGRAPHICS AND BASELINE NARCOLEPSY SYMPTOMS BETWEEN PARTICIPANTS WITH NT1 AND NT2 FROM REST-ON

sodium oxybate ER (FT218) - Avadel

Yves Dauvilliers1; Thomas Roth2; Michael Thorpy3; Anne Morse4; Clete Kushida5; John Harsh6; Luis Ortiz7; Jennifer Gudeman8

Jun 11, 2024